Bernard Poussot Elected CEO of Wyeth - - BioPharm International

ADVERTISEMENT

Bernard Poussot Elected CEO of Wyeth

BioPharm Bulletin

Wyeth (Madison, NJ) has elected Bernard Poussot president and chief executive officer (CEO), effective January 1, 2008. Poussot began his career at Wyeth in 1986. In April 2006, Poussot was promoted to president and vice chairman of Wyeth, and in January 2007, he was promoted to president, chief operating officer, and vice chairman. Robert Essner, current chairman and CEO, will continue as chairman of the board of directors after his term as CEO ends at the end of 2007.

Wyeth’s release

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here